New Oral Anticoagulants vs. Vitamin K Antagonists Among Patients With Cardiac Amyloidosis: Prognostic Impact

New Oral Anticoagulants vs. Vitamin K Antagonists Among Patients With Cardiac Amyloidosis: Prognostic Impact

Background: Atrial arrhythmia (AA) is common among patients with cardiac amyloidosis (CA), who have an increased risk of intracardiac thrombus. The aim of this study was to explore the prognostic impact of vitamin K-antagonists (VKA) and direct oral anticoagulants (DOAC) in patients with CA.Methods...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Eve Cariou, Kevin Sanchis, Khailène Rguez, Virginie Blanchard, Stephanie Cazalbou, Pauline Fournier, Antoine Huart, Murielle Roussel, Pascal Cintas, Michel Galinier, Didier Carrié, Philippe Maury, Yoan Lavie-Badie, Olivier Lairez
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
cardiac amyloidosis
direct oral anticoagulants
vitamin K-antagonists (VKAs)
prognosis
atrial arrhythmia
Diseases of the circulatory (Cardiovascular) system
RC666-701
Acceso en línea:https://doaj.org/article/435fa4c4080545f590084dc89085847d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/435fa4c4080545f590084dc89085847d

Ejemplares similares